Technical Analysis for AVDL - Avadel Pharmaceuticals plc

Grade Last Price % Change Price Change
C 15.77 -0.94% -0.15
AVDL closed down 0.94 percent on Monday, March 18, 2024, on 47 percent of normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Wide Bands Range Expansion -0.94%
Overbought Stochastic Strength -0.94%
NR7 Range Contraction -2.05%
Narrow Range Bar Range Contraction -2.05%
Wide Bands Range Expansion -2.05%
Overbought Stochastic Strength -2.05%
Wide Bands Range Expansion -1.93%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 15 hours ago
Up 1% about 15 hours ago
Down 1% about 15 hours ago
Fell Below Previous Day's Low about 16 hours ago
Down 1% 3 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avadel Pharmaceuticals plc Description

Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company primarily develops FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. It also markets three sterile injectable drugs used in the hospital setting, including Akovaz that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia; Bloxiverz, a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; and Vazculep, a phenylephrine hydrochloride injection indicated for the treatment of clinically important hypotension. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Drugs Organ Systems Surgery Psychoactive Drugs Chloride Reversal Amines Anesthesia Sleep Disorders Narcolepsy Choline Phenols Cataplexy Cholinesterase Phenylephrine Muscle Relaxants

Is AVDL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.24
52 Week Low 8.0
Average Volume 1,408,529
200-Day Moving Average 13.33
50-Day Moving Average 14.64
20-Day Moving Average 14.63
10-Day Moving Average 16.04
Average True Range 0.81
RSI (14) 58.51
ADX 31.08
+DI 25.05
-DI 12.98
Chandelier Exit (Long, 3 ATRs) 14.56
Chandelier Exit (Short, 3 ATRs) 14.26
Upper Bollinger Bands 17.81
Lower Bollinger Band 11.45
Percent B (%b) 0.68
BandWidth 43.42
MACD Line 0.56
MACD Signal Line 0.43
MACD Histogram 0.1247
Fundamentals Value
Market Cap 1.42 Billion
Num Shares 89.8 Million
EPS -2.15
Price-to-Earnings (P/E) Ratio -7.33
Price-to-Sales 157.87
Price-to-Book 11.76
PEG Ratio 0.07
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.37
Resistance 3 (R3) 16.41 16.26 16.27
Resistance 2 (R2) 16.26 16.10 16.24 16.24
Resistance 1 (R1) 16.01 16.01 15.94 15.97 16.20
Pivot Point 15.86 15.86 15.82 15.84 15.86
Support 1 (S1) 15.61 15.70 15.54 15.57 15.34
Support 2 (S2) 15.46 15.61 15.44 15.30
Support 3 (S3) 15.21 15.46 15.27
Support 4 (S4) 15.17